| Up-regulated GO in relatives with ACCP+ |
N, entities |
| • Innate immune response |
33 |
| • Interferon type 1 response |
5 |
| • Interferon gamma response |
10 |
| • Leukocyte activation |
17 |
| • Leukocyte migration |
12 |
| • Myeloid lineage differentiation |
12 |
| • Leukocyte differentiation |
10 |
| • Purine-containing compound catabolic process |
24 |
| • Cellular response to cytokine stimulus |
25 |
| • Cellular response to organonitrogen compounds |
18 |
| • Cellular response to hormones |
20 |
| • Chemotaxis |
23 |
| • Cellular response to insulin stimulus |
10 |
| • Cellular response to chemical stimulus |
88 |
| Up-regulated GO in patients with RA, |
N, entities |
| • Inflammatory response |
8 |
| • Cell projection organization |
21 |
| • Signal transduction |
89 |
| • Cellular response to chemical stimulus |
41 |
| • Defense response |
27 |
| • Immune response |
19 |
| • Cellular response to stress |
29 |
| • Regulation of metabolic process |
122 |
| • Positive regulation of immune system process |
17 |
| • Cell surface receptor signaling pathway |
49 |
| • Cellular protein modification process |
56 |
| • Brain development |
21 |
| • Cellular nitrogen compound metabolic process |
72 |
